Wegovy 2.4mg clicks: what you're dialling and why it matters

You've clicked the pen, here's what actually happened

Picture it: you've removed the cap, attached the needle, and pressed the button. You heard a click, held for ten seconds, and removed the pen. That sequence is intentional design, not a dose-counting method. The Wegovy pen (semaglutide, made by Novo Nordisk) is a pre-filled, pre-set auto-injector. Each pen in the titration range contains one strength of semaglutide in a fixed volume. When you reach the 2.4mg pen, pressing and holding the button releases the full 2.4mg dose in one action. There is no dialling required and no clicks to tally.

The click or sound some people notice is usually the mechanism engaging or the needle retracting, depending on which pen format you have. If you are unsure whether your injection completed successfully (for instance, if the dose counter window did not move to zero, or liquid appeared at the injection site) the Patient Information Leaflet that came with your pen gives specific guidance for that scenario, and your prescriber or pharmacist can advise. The detailed breakdown of the 2.4mg Wegovy pen mechanism covers this in more depth if you want to work through the steps.

The five steps that lead to 2.4mg, and why you don't skip them

The reason people search for 2.4mg clicks is often tied to where they are on the titration ladder. Wegovy's licensed schedule begins at 0.25mg for the first four weeks, a dose that exists primarily to let your body adjust, not to produce significant weight loss, and our guide to your first dose of Wegovy walks you through exactly what to expect in that opening period. From there the standard pathway moves through 0.5mg, 1.0mg and 1.7mg, spending roughly four weeks at each rung before reaching the 2.4mg maintenance dose.

Each step up is clinically intentional. The gastrointestinal side effects (nausea, loose stools, discomfort after eating) are most pronounced when semaglutide is new to your system or when the dose increases. Slower titration reduces the severity and duration of those effects for most people. Skipping a step is not something to do without speaking to your prescriber first; it is not simply a matter of clicking differently. The full Wegovy dose range page sets out what each strength is designed to achieve if you want the wider picture.

For anyone currently at the 1.7mg stage and preparing for the move to maintenance, the 1.7mg dose guide explains what to expect at that penultimate step.

What 2.4mg semaglutide actually does once you're there

Semaglutide acts on GLP-1 receptors involved in appetite regulation and gastric emptying. At the 2.4mg maintenance dose, most people find their hunger reduces noticeably and they feel full on smaller portions. In the STEP 1 clinical trial (a 68-week study of adults with obesity using the 2.4mg dose alongside lifestyle changes) average body-weight reduction was around 15%, as reported in the New England Journal of Medicine. Those are trial figures; individual results vary, and weight management medicines work alongside, not instead of, changes to diet and activity.

The NHS's semaglutide medicines guide covers what to expect at maintenance and the side-effect profile in plain language. Common effects at this dose are gastrointestinal: nausea tends to be the most frequently reported, particularly after a dose increase, though it usually settles within a couple of weeks. Less common but important to know: if you develop severe or persistent stomach pain that travels toward your back, seek medical attention promptly, this can be a sign of pancreatitis, which the MHRA has flagged as a known, if infrequent, risk with GLP-1 medicines.

It is also worth knowing that the MHRA has now approved a 7.2mg maintenance dose for eligible adults, delivered via a dedicated single-dose pen. Whether that is appropriate for you is entirely a clinical question, one for your prescriber to assess based on your response to treatment so far.

So where does your prescriber fit in, and what can nume offer?

The clicks question matters precisely because people want to take their medicine correctly. That instinct is the right one. But the pen's mechanism is only one part of the picture. What dose you should be on, whether your titration is on track, and what to do if a week's injection is delayed, those decisions sit with a clinician who knows your case.

If you are exploring treatment for the first time, the full guide to Wegovy in the UK covers eligibility, how it's prescribed privately and what the process involves. For context on the cost of treatment, including what a private prescription typically includes, the Wegovy cost breakdown is a practical starting point. At nume, a named GPhC-registered prescriber (not a decision algorithm) reviews every consultation the same day it is submitted. Your pen, if treatment is clinically suitable, arrives via DPD the next working day in plain, unbranded packaging. Nothing about the box signals what's inside.

If you have questions about your current prescription or want to understand your titration plan in more detail, our aftercare team is available seven days a week. For anyone ready to start the process from scratch, speak to our prescribers through a free consultation and get a clinical answer to what is right for you specifically.